Tag: NASDAQ:CADX

  • Biotech Stocks Touching New Highs: JAZZ, ANI Pharmaceuticals Inc (NASDAQ:ANIP), Synageva BioPharma Corp (NASDAQ:GEVA), Cadence Pharmaceuticals (NASDAQ:CADX)

    Jazz Pharmaceuticals plc- Ordinary Shares (NASDAQ:JAZZ) has made commercial availability of Versacloz (clozapine, USP) oral suspension in the US. Versacloz is the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behaviour with schizophrenia or schizoaffective disorder. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) stock opened at $169.67 in last session, and closed at $170.28, while the day range of stock is $167.21 – $175.00. The stock showed a positive weekly performance of 9.06%.

    ANI Pharmaceuticals Inc. (NASDAQ:ANIP) rose more than 11 percent to close Tuesday’s trading at $23.96 following stellar Q4 results. Fourth quarter net revenues were $10.5 million, an increase of 98% over the year-ago quarter, thanks to a 170% increase in net prescription sales driven by increased sales of and price increases for the company’s Esterified Estrogen with Methyltestosterone Tablet product. ANI Pharmaceuticals Inc (NASDAQ:ANIP) stock opened at $24.10, in last session and closed at $26.81, by gaining 11.89%. The 52 week range of the stock is $4.80 – $28.19. Company’s market capitalization is $256.04 million.

    Investment analysts at Canaccord Genuity boosted their price target on shares of Synageva BioPharma Corp. (NASDAQ:GEVA) from $105.00 to $125.00 in a note issued to investors on Friday, Analyst Ratings Networkreports. The firm currently has a “buy” rating on the stock. Synageva BioPharma Corp (NASDAQ:GEVA) stock advanced 5.05% and finished the last session at $106.71. The EPS of the stock remained -3.02. Company’s market capitalization is $3.12 billion.

    Cadence Pharmaceuticals (NASDAQ:CADX) was downgraded by Guggenheim from a “buy” rating to a “neutral” rating in a research note issued on Friday, TheFlyOnTheWall.com reports. Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) stock opened the session at $14.00, and closed the session at $14.17. The 52 week range of the stock remained $4.45 – $14.24 and the day range was $13.98 – $14.24.